We are live on ! Find out more
CPH

C Partners Holding Portfolio holdings

AUM $317M
1-Year Est. Return 4.76%
This Fund
S&P 500
This Quarter Est. Return
-8.49%
1 Year Est. Return
-4.76%
3 Year Est. Return
+31.57%
5 Year Est. Return
+26.92%
10 Year Est. Return
+222.73%
AUM
$181M
AUM Growth
-$32.1M
Cap. Flow
-$8.44M
Cap. Flow %
-4.65%
Top 10 Hldgs %
83.13%
Holding
44
New
1
Increased
2
Reduced
1
Closed
26

Top Buys

Rank Stock Value
1
CFMS
Conformis, Inc. Common Stock
CFMS
+$29.5M
2
ICE icon
Intercontinental Exchange
ICE
+$4.63M
3
XOM icon
ExxonMobil
XOM
+$2.31M

Top Sells

Rank Stock Value
1
ADMS
Adamas Pharmaceuticals
ADMS
+$3.69M
2
CELG
Celgene Corp
CELG
+$3.59M
3
JNJ icon
Johnson & Johnson
JNJ
+$2.93M
4
VTRS icon
Viatris
VTRS
+$2.6M
5
ABT icon
Abbott
ABT
+$2.56M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.24%
2 Materials 6.04%
3 Consumer Staples 5.29%
4 Financials 5.23%
5 Industrials 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$618B
– –
-30,089
Closed -$2.93M
MDT icon
27
Medtronic
MDT
$109B
– –
-34,000
Closed -$2.52M
PFE icon
28
Pfizer
PFE
$143B
– –
-52,700
Closed -$1.68M
PRGO icon
29
Perrigo
PRGO
$1.4B
– –
-9,262
Closed -$1.71M
RVTY icon
30
Revvity
RVTY
$12.6B
– –
-33,000
Closed -$1.74M
SYK icon
31
Stryker
SYK
$125B
– –
-8,000
Closed -$765K
TEVA icon
32
Teva Pharmaceuticals
TEVA
$40.8B
– –
-26,000
Closed -$1.54M
TMO icon
33
Thermo Fisher Scientific
TMO
$213B
– –
-6,300
Closed -$817K
VTRS icon
34
Viatris
VTRS
$20.4B
– –
-38,248
Closed -$2.6M
SCPX
35
DELISTED
Scorpius Holdings, Inc.
SCPX
– –
0
– -$300K
ALPN
36
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-6,500
Closed -$394K
SYNH
37
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-30,000
Closed -$1.2M
RDUS
38
DELISTED
Radius Health, Inc.
RDUS
– –
-8,100
Closed -$548K
ALXN
39
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-5,250
Closed -$949K
AKRX
40
DELISTED
Akorn Inc
AKRX
– –
-42,000
Closed -$1.83M
PTX
41
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
– –
-14,500
Closed -$858K
BDSI
42
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-160,000
Closed -$1.27M
CELG
43
DELISTED
Celgene Corp
CELG
– –
-31,000
Closed -$3.59M
AIRM
44
DELISTED
Air Methods Corp
AIRM
– –
-13,000
Closed -$537K
1
2

Similar funds

KI
Keewaydin Investments Southampton, New York $317M AUM
CPW
Crestmont Private Wealth Houston, Texas $317M AUM 15.31% 1-Year Est. Return
GWP
Gen-Wealth Partners Zeeland, Michigan $317M AUM 17.24% 1-Year Est. Return
TM
TigerOak Management Albuquerque, New Mexico $317M AUM 25.39% 1-Year Est. Return
WIS
Wright Investors Service Shelton, Connecticut $318M AUM 33.9% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
FNWM
Financial Network Wealth Management Draper, Utah $316M AUM
GBFG
Gerald Baker Financial Group Arlington, Texas $316M AUM

C Partners Holding's Q3 2015 Portfolio in Review

As of Q3 2015, C Partners Holding held 44 positions worth $181M, down 15% from $213M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

C Partners Holding withdrew a net $8.44M in Q3 2015, closing 26 positions and reducing 1 holding. Its most notable exit was Celgene Corp, an estimated $3.59M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.2% of assets, up from 6.6% a quarter earlier, followed by Materials and Consumer Staples.

Against the trend, C Partners Holding opened a new position in Conformis, Inc. Common Stock worth $26.4M.

  • C Partners Holding's largest Q3 2015 buy was Conformis, Inc. Common Stock: 58,506 shares worth $26.4M.
  • C Partners Holding added most to Intercontinental Exchange in Q3 2015, an estimated $4.63M increase.
  • C Partners Holding's biggest Q3 2015 reduction was Adamas Pharmaceuticals, cutting an estimated $3.69M.
  • C Partners Holding fully exited Celgene Corp in Q3 2015, selling an estimated $3.59M.
  • C Partners Holding's ten largest holdings make up 83% of its $181M portfolio in Q3 2015.
  • C Partners Holding opened 1 new position and closed 26 in Q3 2015.
  • C Partners Holding's portfolio value fell 15% quarter-over-quarter to $181M.

Based on C Partners Holding's 13F filing for Q3 2015, filed 12 Nov 2015.